BUSINESS WIRE

Samenvatting: RevBio ontvangt goedkeuring om een tandheelkundig klinisch onderzoek te starten in Italië voor zijn regeneratief biomateriaal

Prior studies have demonstrated that TETRANITE® is replaced with bone via substitution as it dissolves, stimulating osteoblast cells to produce osteoid (bone precursor) which is then mineralized during the process of bone maturation. (Graphic: Business Wire)
Prior studies have demonstrated that TETRANITE® is replaced with bone via substitution as it dissolves, stimulating osteoblast cells to produce osteoid (bone precursor) which is then mineralized during the process of bone maturation. (Graphic: Business Wire)
In voller Größe anschauen Opens in new window

Download-Formate